Analyst initiations: AMAG, CPO and ALO
Posted Feb 4th 2008 10:50AM by Laurie Pasternack
Filed under: Baxter Intl (BAX), Analyst Initiations
.gif)
MOST NOTEWORTHY: Amag Pharmaceuticals, Corn Products and Alpharma were today's noteworthy initiations:
- Baird initiated Amag Pharmaceuticals (NASDAQ: AMAG) with an Outperform rating and believes concerns regarding ferumoxytol approvability are misplaced.
- JP Morgan assumed coverage of Corn Products (NYSE: CPO) with an Overweight rating and points to the company's growth in emerging markets and improved business economics in its core U.S. market.
- RBC Capital is positive on Alpharma's (NYSE: ALO) Flector opportunity in the U.S. topical NSAID market. The firm started shares with an Outperform rating and $28 target.
OTHER INITIATIONS:
- Merrill resumed coverage of Baxter (NYSE: BAX) with a Buy rating.
- Goldman initiated Teradyne (NYSE: TER) with a Neutral rating and $11 target.
- Allianz AG (NYSE: AZ) was initiated with a Buy rating at Societe Generale.
Tags: Allianz AG, AllianzAg, ALO, Alpharma, AMAG, Amag Pharmaceuticals, AmagPharmaceuticals, AZ, BAX, Baxter, Baxter International, BaxterInternational, Corn Products, CornProducts, CPO, initiations, TER, Teradyne
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
